I'm an independent trader/investor whose primary interests are in the biotech arena.
Education: Harvard Law School; Dartmouth College
Investment Philosophy: I invest both in stocks and options with a focus on long opportunities and believe that by analyzing earlier trial data carefully one can spot opportunities and understand the odds of success of future trials better than others.
I do not listen to those who are paid to give their opinion because I do not believe in their objectivity or their honesty.
I stay away from FDA approval decisions as catalysts as a rule given that they have a strong bias against approving drugs and there are many unseen political forces that can lead to an unanticipated negative decision regardless of the data.
I’M NOT A FINANCIAL ADVISOR AND ONLY GIVE MY OPINIONS. SEEK EXPERT ADVICE ELSEWHERE
MTR Investors Group goal is to provide the best Covered / Naked, Credit Spread, and Iron Condor Option Screeer on the web. Screen over 3,100 stocks and over 270,000 options in seconds to find the best possible trades!
Option writers use our screener to find options trades that have the highest probability of expiring worthless.
Attempting to find profitable option trades on over 3,100 stocks and over 250,000 options, and millions of Credit Spread and Iron Condor combinations is a huge effort. The MTR option screener simplifies that process and will discover trades that otherwise would be missed.
This is an end of day screening service. It is geared toward traders that look for trading opportunities after hours to prepare for the next trading day.
We use Stock Market Scout (SMS) as a model to indicate allocating cash to an index ETF (such as SPY) by going long on Green, cash on Yellow, short on Red (or stay in cash). This is not a recommendation to buy or sell SPY.
We are proud to offer powerful tools for free or at price point that allows any investor to have an edge.
I enjoy life and am very passionate about work. I investigate companies to find stocks that are undervalued. I only purchase stocks that can be held for a minimum of 3-5 years, longer is better. I am an avid reader of anything Warren Buffett and attend his annual shareholder meeting regularly.
A well rounded investor with a knack for what's coming and what will work. I have an interest in companies with disruptive technology and a variety of other niche players. I have proprietary methods of finding undervalued, and under-appreciated stocks with huge potential.